FontsA A
ContrastA A
Newsletter sign-up
I give permission for BBMRI-ERIC to send me their newsletter and emails about subjects which they think may be of interest to me. I can unsubscribe from all emails at any time. I understand that my information will be processed according to BBMRI-ERIC's privacy notice.
Home

I am looking for information as

Researcher

Industry

Patient

Citizen

Member States

B1MG

Beyond 1 Million Genomes

Topic: SC1-HCC-06-2020 – Coordination and Support to better data and secure cross-border digital infrastructures building on European capacities for genomics and personalised medicine

Type of Action: CSA

Duration: 36 months

Start date: 1 June 2020

Grant agreement:951724

Web: https://b1mg-project.eu/

Total request Grant by Consortium: €4,000,000

Total request Grant by BBMRI-ERIC: €157,190.15

Linked Third Parties/BBMRI-ERIC Framework Agreement: Latvian Biomedical Research and Study Centre (BMC – BBMRI.lv), Netherlands Cancer Institute (NKI – BBMRI.nl), and Biomedical Research Foundation of the Academy of Athens (BRFAA – BBMRI.gr)

Benefit/tasks for BBMRI-ERIC: BBMRI-ERIC and its linked third parties contribute to WP2 (ELSI).

Abstract

Personalised medicine brings significant socio-economic benefits, including faster, more accurate diagnostics, the development of pharmacogenomics and the advancement of preventative medicine, resulting in better health and quality of life for patients as well as more efficient national health systems. The EU-funded B1MG project will provide the support and coordination structure for the European 1+ Million Genomes initiative based on the commitment of 20 EU states and Norway to work ‘towards access to at least 1 million sequenced genomes in the EU by 2022’. These countries will engage a range of stakeholders to support the creation of a pan-European genome-based health data infrastructure, encompassing data quality and exchange standards, access protocols and legal guidance.


The website was co-funded within ADOPT BBMRI-ERIC, a project that has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 676550.
We use cookies to analyse the traffic on our websites. All personal data is anonymized and not shared with third parties! Click here for more information.
Accept